Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
York Charles N II
Chief Financial Officer and VP at Spyre Therapeutics. Filing since 15 Aug 2016.
CIK 0001655962
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE
Spyre Therapeutics, Inc.
5 Dec 2017
Chief Financial Officer and VP
Bought
10,241
$48.70K
41.7%
SYRE
Spyre Therapeutics, Inc.
4 Dec 2017
Chief Financial Officer and VP
Bought
3,259
$16.20K
15.3%
SYRE
Spyre Therapeutics, Inc.
1 Dec 2017
Chief Financial Officer and VP
Bought
6,500
$29.86K
44.0%
SYRE
Spyre Therapeutics, Inc.
15 Aug 2017
Chief Financial Officer and VP
Bought
1,959
$4.93K
15.3%
SYRE
Spyre Therapeutics, Inc.
15 Feb 2017
Chief Financial Officer and VP
Bought
2,000
$8.57K
18.5%
SYRE
Spyre Therapeutics, Inc.
15 Aug 2016
Chief Financial Officer and VP
Bought
2,000
$7.97K
22.7%
6 decisions on file.
